Merit Medical Systems (MMSI) Stock Analysis & AI Equity Report

Medical - Instruments & Supplies USD Explore free reports

Merit Medical Systems (MMSI) overview

Merit Medical Systems (MMSI) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 1,516m and operating profit of USD 185m; the year-end share price was 88.14 USD and market capitalisation was USD 5,238m. Merit Medical Systems is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Merit Medical Systems's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,584mFY 2025
Share price88.14 USDFY 2025 year end
RevenueUSD 1,516mFY 2025
Operating profitUSD 185mFY 2025
Net earningsUSD 128mFY 2025
Market capitalisationUSD 5,238mFY 2025 year end

About Merit Medical Systems

Merit Medical Systems designs, develops, manufactures and markets medical devices for interventional, diagnostic and therapeutic procedures. Its products are used across areas including cardiology, radiology, oncology, critical care and endoscopy. Offerings include vascular access devices, needles, introducer sheaths, guide wires and custom procedural kits, trays and packs. Customers include healthcare facilities and clinicians worldwide.

Generate the Merit Medical Systems report

Merit Medical Systems is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Merit Medical Systems and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Merit Medical Systems

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.